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Background: Dry eye syndrome is a frequent complication of refractive surgery. Acupuncture has been widely
used to alleviate the associated symptoms. However, the use of acupuncture for patients who suffer from dry
eye syndrome following refractive surgery has certain drawbacks. This pilot study aims to evaluate the efficacy
of acupuncture treatment in treating the signs and symptoms of dry eye syndrome after refractive surgery.
Methods/design: Forty participants will be randomly assigned to the acupuncture plus usual care group or the
usual care control group. The acupuncture plus usual care group will undergo treatments on seventeen acupuncture
points, three times per week for four weeks. The control group will receive only usual care during the same period.
The primary outcomes will be scores on the Ocular Surface Disease Index (OSDI) and the results of examinations at 1, 3,
5, and 13 weeks. The secondary outcomes will be Tear Film Break-up Time (TBUT), as well as scores on the Schirmer-I
test, visual analog scale (VAS), and quality of life (QOL) questionnaire for the self-assessment of ocular discomfort.
Digital photographs will be taken to document the pattern of fluorescein staining observed on the corneal
surface. The results of the Schirmer-I test, TBUT, and fluorescein-stained corneal surface digital photographs will
be assessed at the screening and at week 13. VAS scores will be assessed at the screening, as well as at 1, 3, 5,
and 13 weeks. QOL will be evaluated at 1, 3, 5, and 13 weeks.
Discussion: This trial will provide primary data with which to investigate the clinical effectiveness and safety of
acupuncture treatment for dry eye syndrome after refractive surgery.
Trial registration: Current Controlled (Identifier: KCT0000727)
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Refractive surgery involves the use of an excimer laser
to ablate the cornea, thereby correcting the patient’s
refractive error [1]. Various types of refractive surgery
have been developed: photorefractive keratectomy (PRK),
laser in situ keratomileusis (LASIK), and laser-assisted
subepithelial keratomileusis (LASEK). Since the excimer
laser was first used to reshape the cornea, the surgery
has been performed on approximately 100,000 patients
in Korea each year [2]. Various other ophthalmological
advancements have improved the safety, efficacy, and* Correspondence: omdjun@kiom.re.kr
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reproduction in any medium, provided the orpredictability of surgical outcomes [3,4]. Despite these
advances, however, certain limitations and complications
remain. These include infection, ectasia, diffuse lamellar
keratitis, subepithelial haze, dry eye, epithelial ingrowth,
and the development of a button-hole flap [5].
Up to 94.8% of patients experience dry eye symptoms
after refractive surgery [6]. The National Evidence-based
healthcare Collaborating Agency (NECA) reported that
17% of refractive surgery patients later suffer from chronic
dry eye [2].
The use of artificial tears and lifestyle modifications
are currently the most common approaches to manage-
ment. However, the preservatives in artificial tears may
exacerbate ocular surface inflammation, and the safetyd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[7,8]. In this context, complementary and alternative
medicine can do much to alleviate the patient’s pain [9-14].
This pilot study focuses on the efficacy of acupuncture
in relieving the signs and symptoms of chronic dry eye
syndrome after refractive surgery.Methods/design
Study design
This is a randomized, controlled pilot trial. All participants
will be randomly allocated to the acupuncture plus usual
care group (n = 20) or the usual care control group (n = 20).
The acupuncture plus usual care group will receive 12
sessions of treatment over a four-week period. The study
design is depicted in Figure 1.Ethics
This study was approved by the Institutional Review Board
(IRB) at the Oriental Hospital of Daejeon University, Korea
(IRB approval number: djomc-98-1) and was registered
with the Clinical Research Information Service at the
Korea National Institute of Health (KCT0000727). Each
participant will provide written informed consent prior
to participation in the study.Figure 1 Study flow chart. a: 5 week (4 weeks after visit 2 + within
3 days), b: 13 week (12 weeks after visit 2 + within 3 days).Recruitment
Participants will be recruited through advertisements in
the local newspaper, distributed leaflets, the university
homepage, and posts on notice boards. At the first
(screening) visit, each participant’s demographic information
(including ocular pathologies and current/prior use of
medications and/or lubricant eye drops) will be recorded.
Study participants who have experienced dry eye symptoms
for at least 24 months after undergoing refractive surgery
will be enrolled in the study. Patients will be included
only if their ocular discomfort is rated ≥ 40 on the visual
analog scale (VAS) and if the associated ophthalmological
test results are abnormal (that is, Tear Film Break-up
Time (TBUT) ≤ 10 seconds, ≤ 10 mm/5 minutes on the
Schirmer-I test) [15] (Table 1).
Randomization and allocation concealment
For randomization and allocation concealment, a set of
random numbers will be generated using computerized
SAS block-randomization software (SASW version 9.3, SAS
Institute, Inc., Cary, NC, USA). Sealed, opaque assignment
envelopes will be used for allocation concealment [16].
The primary data collected will be used to investigate
the impact of expectations on the success of acupuncture
treatment. Because participant expectations could affect
treatment outcomes, each patient will be queried regarding
their perception of acupuncture therapy prior to group
allocation [17]: ‘How much do you expect that the acu-
puncture treatment will relieve your dry eye symptoms?’
Participants will be asked to select one point on a 10-point
Likert scale (0 not useful to 9 very useful).
Intervention
Acupuncture plus usual care group
The acupuncture plus usual care group will be treated
three times per week for four weeks. Each session of
treatment will include the use of 17 acupuncture points
(bilateral BL2, GB14, TE23, Ex1, ST1, GB20, LI4, and
LI11, and single GV23). These will be localized according
to the ‘WHO Standard Acupuncture Point Location in
the Western Pacific Region’ protocol [18]. Four experts
in the field of alternative medicine who have trained for
at least seven years and practiced for at least three years
will perform these treatments using 0.20 mm × 30 mm
disposable acupuncture needles (Dongbang Acupuncture
Inc., Chungnam, Republic of Korea). The ‘de-qi’ sensation
will be induced by twisting acupuncture, and the needles
will be retained for 20 minutes before removal. The pa-
tients will be allowed to use any additional treatment for
dry eye symptoms other than punctal plugs or punctal
occlusion surgery. Patients will not be permitted to par-
ticipate in any other regimen of acupuncture therapy.
Any changes in medical history or vital signs and reports
of adverse events will be recorded at every follow-up visit.
Table 1 Inclusion and exclusion criteria
Inclusion criteria 1. Men and women, 18 to 65 years old
2. Dry eye syndrome in one or both eyes (ICD-10:H04.1) with:
2-1. Refractive surgery within 24 months and dry eye symptoms (for example, ocular itching, foreign body sensation,
burning, pain and dryness, visual disturbance, ocular redness, and/or a sensation of tearing) of at least moderate severity
2-2. VAS score ≥ 40
2-3. TBUT ≤10 seconds and Schirmer-I test results ≤ 10 mm/5 minutes
3. Voluntary participation and written informed consent
Exclusion criteria 1. Dry eye symptoms due to eyelid or eyelash defects
2. Acute infection of the eyelid, eyeball or periorbital area
3. Skin disease such as Stevens-Johnson syndrome and/or pemphigoid
4. Vitamin A deficiency
5. Any external injury to the orbital or periorbital area
6. A history of eye surgery within the past six months (except refractive surgery)
7. Impaired blinking due to facial palsy
8. History of punctal plug or punctal occlusion surgery
9. Pregnancy, lactation, or plans to conceive
10. Exclusion at the investigator’s discretion
VAS: Visual analog scale; TBUT: Tear film break-up time.
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The control group will be allowed to use any type of
treatment for dry eye symptoms: artificial tear drops, drugs,
supplements (for example, cyclosporine, corticosteroids,
and autologous serum), and alternative treatments other
than those listed above as exclusions. Patients will be
followed-up every two weeks and asked to report any
change in medical history or drug use at each visit.Primary outcome
Ocular Surface Disease Index (OSDI)
The primary outcome will be scores on the OSDI, which
is a questionnaire consisting of 12 questions for evaluating
the effects of dry eye syndrome on vision, ocular symptoms,
and any condition associated with dry eye. The patient will
answer each question on a scale ranging from 0 to 4, with 0
indicating ‘none of the time’ and 4 indicating ‘all of the
time’. If a certain question is deemed irrelevant, it will be
marked as ‘not applicable (N/A)’ and excluded from the
analysis. The OSDI score is calculated according to the
following formula [19]:
OSDI ¼ Sum of scores for all questions answeredð Þ  100
Total number of questions answeredð Þ  4
The scale ranges from 0 to 100, with higher scores
representing more severe cases of dry eye syndrome
[20]. This value will be checked during visits 2 (prior to
acupuncture treatment), 8, 14, and 15.Secondary outcomes
Visual Analog Scale (VAS)
The 100-mm VAS is an instrument for the self-assessment
of ocular discomfort. Patients will perform these measure-
ments daily for one week. Each participant will mark
the level of ocular discomfort (for example, ocular itching,
foreign body sensation, burning, pain, and dryness). The
VAS score is determined by measuring the distance between
the left-hand end of the line and the point marked by
the subject. This will be checked during visits 1, 2, 8,
14, and 15. The VAS scores as reported at visit 1 will be
used for screening purposes. The VAS scores obtained
at visit 2 will be used as baseline for the analysis.Quality of Life (QOL)
The QOL scale is used to measure the effect of dry eye
on the patient’s quality of life. The question is posed as
follows: ‘During the last week, how would rate your quality
of life, considering any impact of dry eye symptoms?’ The
possible responses range from 0 (excellent) to 6 (worst).
This will be measured at visits 2, 8, 14, and 15.Tear Film Break-up Time (TBUT)
The TBUT test assesses tear film stability. Sodium fluores-
cein (2.5%) is applied to both eyes, and the time that elapses
until the first appearance of a dry spot or disruption in the
tear film is measured. A single optometrist performed all
TBUT measurements, without holding the participant’s
eyelid. TBUT results ≤ 10 seconds suggest dry eye of at
Jang et al. Trials 2013, 14:351 Page 4 of 6
http://www.trialsjournal.com/content/14/1/351least moderate severity. The TBUT will be assessed at
visits 1 (screening) and 15.
Schirmer-I test (with anesthesia)
The Schirmer-I test (with anesthesia) is used to measure
baseline tear secretion. After the application of local
anesthesia (AlcaineW Alcon, Inc., Texas, USA) to arrest
reflex tearing, Schirmer test paper (Color Bar™ Schirmer
tear test, Eagle Vision, Inc., TN, USA) is placed in the
lateral third of the lower eyelid. With closed eyes, the
patient keeps this paper in place for five minutes, after
which the length of the wet portion is measured. This
measurement will be obtained during visits 1 (screening)
and 15. If the Schirmer-I test result is ≤ 10 mm/5 minutes,
the patient’s dry eye is of moderate severity or worse.
Corneal surface photography
Digital photos will be used to evaluate the corneal surface
as revealed by fluorescein staining. After dropping one
drop of fluorescein 0.25% in each eye, participants will
be asked to blink five times to drain any excess dye.
The stained corneal surface will be photographed using
the cobalt blue filter and yellow filter on the slit-lamp
biomicroscope. The results will be graded according to
the Oxford scheme (from 0 (absent) to 5 (severe)) and
checked during visits 1 and 15 [21].
Efficacy of drug or other treatment
From visit 14 onward, all participants will be reminded that
they can use any sort of treatment except for surgery or
acupuncture. Patients will be asked to record any changes
in medical history or treatment regimen in a diary. This
will be collected for review at the last visit (visit 15).
General assessment
A general assessment will be carried out in which both
practitioners and participants will assess the improvement
in symptoms related to dry eye syndrome after acupunctureTable 2 Evaluation plan
Screening
Week 1





Corneal surface photography ●
QOL ●
Drug or therapeutic modalities
General assessment
a: 4 weeks after visit 2 + 3 days; b: 12 weeks after visit 2 + 3 days; ●: All groups.
OSDI: Ocular surface disease index; VAS: Visual analog scale; TBUT: Tear film break-uor the conventional treatment regimen. The patient’s
condition will be graded as excellent, good, fair, no change,
or aggravated (Table 2).
Statistical analysis
Because this is an exploratory pilot study designed to
evaluate the feasibility of acupuncture for the treatment
of dry eye syndrome after refractive surgery, sample size
was not calculated according to the conventional power
analysis method. Twenty subjects will be recruited for
each group.
The statistical analysis will be conducted using SAS
software (version 9.3, SAS Institute Inc., Cary, NC, USA)
with the significance level set at 0.05. Efficacy measure-
ments were adjusted by intention to treat analysis (ITT).
Missing values will be imputed by the last observation
carried forward (LOCF) method. Analysis of covariance
(ANCOVA) will be used to test measured outcomes
(OSDI, TBUT, Schirmer-I test, QOL and VAS for the
self-assessment of ocular discomfort). ANCOVA will be
used to determine whether dependent variable values
are equivalent across levels of a categorical independent
variable by statistically controlling for the effects of other
variables known as covariates. The change in scores for
each group will serve as the dependent variable, the
baseline scores will serve as covariates, and the group
will serve as the fixed factor. The Chi-square test or
Fisher’s exact test will be used to identify any differences
among groups in fluorescein staining of the corneal
surface.
Using this correlation analysis, we will evaluate the
relationship between patients’ expectations of acupuncture
treatment and the relief of dry eye symptoms in the
acupuncture plus usual care group.
Adverse events
Adverse events are unexpected signs, symptoms or diseases
encountered during the clinical trial, whether or notTreatment or observation Assessment
2 3 4 5a 13b









p time; QOL: quality of life.
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and psychological adverse events may be observed. Local
symptoms may include continual swelling, redness and
itching lasting ≥ three days, peripheral neuritis and
hemorrhage, and bruises/pain lasting ≥ two weeks. Systemic
symptoms include headaches lasting longer than three
days and circulatory problems, including dizziness and
palpitations. Psychological problems include hypersen-
sitivity for over three days and anxiety or fear for over
60 hours. All unexpected responses related to acupuncture
treatment will be recorded. In order to prevent bias, an
expert panel of individuals who are not otherwise
connected to this study will evaluate any report of an
adverse event. Each report will include a description of
any associated symptoms, including the date of onset,
the duration, and the degree of severity (Spilker’s criteria
[22]: 1 = mild, 2 = moderate and 3 = severe, the pa-
tient’s perception of a causal relationship with the treat-
ment (1 = definitely related, 2 = probably related, 3 =
possibly related, 4 = probably not related, 5 = definitely
not related and 6 = unknown), acupuncture-related action
(1 = no change, 2 = temporarily suspend, 3 = suspend),
treatment of the adverse event and treatment results. If ser-
ious adverse events (SAE) occur, these will be related to the
IRB; experimental treatments will be stopped immediately
and appropriate treatments will be administered.Discussion
Approximately 95% of patients suffer from symptoms
of dry eye after refractive surgery. These patients may
attempt to alleviate their symptoms using artificial tears,
punctal occlusion surgery and/or lifestyle modifications
[6,23]. Dry eye symptoms after refractive surgery are most
commonly caused by iatrogenic corneal nerve damage,
which contributes to a loss of corneal sensation [24].
This decrease in sensitivity can result in tear film
instability, reduced tear secretion, a decrease in the
number of conjunctival goblet cells and/or an increase
in tear osmolality. Furthermore, there is evidence that
the use of a corneal flap with a superior hinge can decrease
corneal sensitivity, potentially leading to a reduction in the
blink rate [23].
Prior studies have shown that acupuncture can modulate
the autonomic nervous system and immune system, which
in turn can increase lacrimal secretion by stimulating
lacrimal gland function [14,25-27]. No previous study has
examined the effects of acupuncture in the treatment of
dry eye syndrome following refractive surgery. This pilot
study will show whether acupuncture is effective in the
treatment of postoperative dry eye syndrome [9-14]. The
results should allow us to evaluate the feasibility of an
extensive clinical study and to predict the number of
subjects necessary for sufficient power.Trial status
Patient recruitment began in January 2013 and will continue
until December 2013.
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